Physician profile
Mark E Flanum
NPI 1184675126
$3,451.30
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $172 · 2020: $826 · 2021: $284 · 2022: $445 · 2023: $34.40 · 2024: $1,690.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,259 · Food and Beverage: $466.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,258.58 |
| Food and Beverage | $466.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,440.09 | 2021-2024 | Cd Horizon Spinal System, Plasmablade(Tm) |
| Globus Medical, INC. | $625.30 | 2020 | |
| Arthrex, INC. | $283.65 | 2024 | |
| Orthofix Medical, INC. | $246.71 | 2021-2022 | |
| Depuy Synthes Sales INC. | $181.47 | 2020 | |
| Medtronic USA, INC. | $171.63 | 2019 | |
| Cerapedics INC. | $148.13 | 2021-2022 | |
| Surgalign Spine Technologies, INC. | $125.10 | 2022 | |
| Kci USA, INC. | $91.19 | 2022 | |
| Ethicon US, LLC | $68.17 | 2022 | |
| Welch Allyn | $19.30 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $18.92 | 2023 | Exparel |
| Bioventus LLC | $16.16 | 2022 | |
| Si-Bone, INC. | $15.48 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Flanum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.